Human breast cancer cells: parental v.s lapatinib-resistant clone

ABSTRACT: Transcriptional profiling of human HER2-positive BT474 breast cancer cells comparing control untreated cancer cells with lapatinib-resistant clone established by chronic treatment with lapatinib Two-condition experiment, parental cells vs. lapatinib-resistant (LR) clone.

ORGANISM(S): Homo sapiens

SUBMITTER: Wei-Chien Huang 

PROVIDER: E-GEOD-51889 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress